leon-nanodrugs GmbH, the leading enabler of nano technology for the pharmaceutical industry, announced today that it has successfully completed a Series B funding round. The capital will be used to further strengthen the company’s leadership position in the provision of nano solutions for the pharmaceutical and biotechnology industries.


leon delivers novel, validated and optimized solutions that create value for clients and provide better outcomes for their patients. It expedites API’s to deliver enhanced bioavailability, increased solubility and improved stability, revitalizing forgotten formulations, and breathing new life into generics.

leon Secures Series B Funding to Accelerate Growth in Enabling Nano Now, While Establishing Strategic Partnership with Evotec

leon Secures Series B Funding to Accelerate Growth in Enabling Nano Now, While Establishing Strategic Partnership with Evotec

Company Info

Related People